Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Louise Schilder"'
Autor:
Maria C. Ferrández, Sandeep S. V. Golla, Jakoba J. Eertink, Bart M. de Vries, Sanne E. Wiegers, Gerben J. C. Zwezerijnen, Simone Pieplenbosch, Louise Schilder, Martijn W. Heymans, Josée M. Zijlstra, Ronald Boellaard
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Background Convolutional neural networks (CNNs), applied to baseline [18F]-FDG PET/CT maximum intensity projections (MIPs), show potential for treatment outcome prediction in diffuse large B-cell lymphoma (DLBCL). The aim of this study is to
Externí odkaz:
https://doaj.org/article/cbda86c527ec46e18d80e8f0c03767b8
Autor:
Albertine M B van der Does, Eva L Kneepkens, Elien B Uitvlugt, Sanne L Jansen, Louise Schilder, George Tokmaji, Sofieke C Wijers, Marijn Radersma, J Nina M Heijnen, Paul F A Teunissen, Pim B J E Hulshof, Geke M Overvliet, Carl E H Siegert, Fatma Karapinar-Çarkit
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0229940 (2020)
ObjectivesTo identify the preventability, determinants and causes of unplanned hospital readmissions within 30 days of discharge using a multidisciplinary approach and including patients' perspectives.DesignA prospective cross-sectional single-center
Externí odkaz:
https://doaj.org/article/129893e73c0f4c8382765f5339da0683
Autor:
Susanne Stads, Louise Schilder, S Azam Nurmohamed, Frank H Bosch, Ilse M Purmer, Sylvia S den Boer, Cynthia G Kleppe, Marc G Vervloet, Albertus Beishuizen, Armand R J Girbes, Pieter M Ter Wee, Diederik Gommers, A B Johan Groeneveld, Heleen M Oudemans-van Straaten, CASH study group
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0197301 (2018)
INTRODUCTION:Acute kidney injury (AKI) requiring renal replacement therapy (RRT) is associated with high mortality. The creatinine-based stage of AKI is considered when deciding to start or delay RRT. However, creatinine is not only determined by ren
Externí odkaz:
https://doaj.org/article/3ecfa4abf947495692a5a90a1ff5f996
Autor:
Geke M. Overvliet, J. Nina M. Heijnen, Sanne L. Jansen, Fatma Karapinar-Çarkit, Pim B. J. E. Hulshof, Marijn Radersma, George Tokmaji, Eva L. Kneepkens, Sofieke C. Wijers, Albertine M. B. van der Does, Carl E. H. Siegert, Paul F. Teunissen, Louise Schilder, Elien B. Uitvlugt
Publikováno v:
PLoS One, 15
PLoS ONE
PLoS One, 15, 4
PLoS ONE, Vol 15, Iss 4, p e0229940 (2020)
PLoS ONE
PLoS One, 15, 4
PLoS ONE, Vol 15, Iss 4, p e0229940 (2020)
Contains fulltext : 220997.pdf (Publisher’s version ) (Open Access) OBJECTIVES: To identify the preventability, determinants and causes of unplanned hospital readmissions within 30 days of discharge using a multidisciplinary approach and including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f8d07d13bc0975819efba8e67c9e8f5
http://hdl.handle.net/2066/220997
http://hdl.handle.net/2066/220997
Autor:
Louise Schilder, Birgit I. Lissenberg-Witte, Zoé L. E. van Kempen, Bernard M. J. Uitdehaag, Joep Killestein, Johannis A. van Rossum
Publikováno v:
van Rossum, J A, van Kempen, Z L E, Schilder, L, Lissenberg-Witte, B I, Uitdehaag, B & Killestein, J 2019, ' Abnormalities and erythroblasts in peripheral blood of multiple sclerosis patients treated with natalizumab ', Multiple Sclerosis and Related Disorders, vol. 36, 101382 . https://doi.org/10.1016/j.msard.2019.101382
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 36:101382. Elsevier
Multiple Sclerosis and Related Disorders, 36:101382. Elsevier
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 36:101382. Elsevier
Multiple Sclerosis and Related Disorders, 36:101382. Elsevier
Background In natalizumab treated patients several hematopoietic abnormalities including erythroblasts, myeloblasts and neutrophilic precursors in peripheral blood have been described. So far, long term effects of the hematopoietic changes have not b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5382397907f124f35bb6dcbf0a837b2
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072303149&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072303149&origin=inward
Autor:
S. Azam Nurmohamed, Robert H.J. Beelen, Nanne J. Paauw, Pieter M. ter Wee, Louise Schilder, A. B. Johan Groeneveld, Armand R. J. Girbes, Albertus Beishuizen
Publikováno v:
Schilder, L, Nurmohamed, S A, ter Wee, P M, Paauw, N J, Girbes, A R J, Beishuizen, A, Beelen, R H J & Groeneveld, A B J 2015, ' Coagulation, Fibrinolysis and Inhibitors in Failing Filters during Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: Effect of Anticoagulation Modalities ', Blood Purification, vol. 39, no. 4, pp. 297-305 . https://doi.org/10.1159/000380904
Blood Purification, 39(4), 297-305. Karger
Blood Purification, 39(4), 297-305. S. Karger AG
Blood Purification, 39(4), 297-305. Karger
Blood Purification, 39(4), 297-305. S. Karger AG
Introduction: The mechanisms of early filter failure and clotting with different anticoagulation modalities during continuous venovenous hemofiltration (CVVH) are largely unknown. Methods: Citrate, heparin and no anticoagulation were compared. Blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::045f8c11cbec56b0a65d5d49bf2b0802
https://doi.org/10.1159/000380904
https://doi.org/10.1159/000380904
Autor:
Louise Schilder, Pieter M. ter Wee, Robert H.J. Beelen, Albertus Beishuizen, Armand R. J. Girbes, Nanne J. Paauw, S Azam Nurmohamed, A. B. Johan Groeneveld
Publikováno v:
Schilder, L, Nurmohamed, S A, ter Wee, P M, Paauw, N J, Girbes, A R J, Beishuizen, A, Beelen, R H J & Groeneveld, A B J 2015, ' Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalities ', BMC Nephrology, vol. 16, 178 . https://doi.org/10.1186/s12882-015-0167-5
BMC Nephrology
BMC Nephrology, 16. BioMed Central Ltd.
BMC Nephrology, 16:178. BioMed Central
BMC Nephrology
BMC Nephrology, 16. BioMed Central Ltd.
BMC Nephrology, 16:178. BioMed Central
Background: Novel putative mediators of acute kidney injury (AKI) include immune-cell derived tumour necrosis factor-like weak inducer of apoptosis (TWEAK), angiopoietin-2 (Ang-2) and protein pentraxin-3 (PTX3). The effect of continuous venovenous he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d8ef653ee7bf7f24ad089da12b235af
https://research.vumc.nl/en/publications/3a506d82-bbb4-41c3-9a81-764984813776
https://research.vumc.nl/en/publications/3a506d82-bbb4-41c3-9a81-764984813776
Autor:
Pieter M. ter Wee, Nanne J. Paauw, Louise Schilder, Robert H.J. Beelen, Armand R. J. Girbes, A. B. Johan Groeneveld, Albertus Beishuizen, S Azam Nurmohamed
Publikováno v:
Critical Care, 18(2):R78. Springer Science + Business Media
Critical Care, 18(2). BioMed Central Ltd.
Schilder, L, Nurmohamed, S A, ter Wee, P M, Paauw, N J, Girbes, A R J, Beishuizen, A, Beelen, R H J & Groeneveld, A B J 2014, ' The plasma level and biomarker value of neutrophil gelatinase-associated lipocalin in critically ill patients with acute kidney injury are not affected by continuous venovenous hemofiltration and anticoagulation applied ', Critical Care, vol. 18, no. 2, R78 . https://doi.org/10.1186/cc13838
Critical Care
Critical Care, 18(2). BioMed Central Ltd.
Schilder, L, Nurmohamed, S A, ter Wee, P M, Paauw, N J, Girbes, A R J, Beishuizen, A, Beelen, R H J & Groeneveld, A B J 2014, ' The plasma level and biomarker value of neutrophil gelatinase-associated lipocalin in critically ill patients with acute kidney injury are not affected by continuous venovenous hemofiltration and anticoagulation applied ', Critical Care, vol. 18, no. 2, R78 . https://doi.org/10.1186/cc13838
Critical Care
Introduction: Neutrophil gelatinase-associated lipocalin (NGAL) is a biomarker of acute kidney injury (AKI), and levels reflect severity of disease in critically ill patients. However, continuous venovenous hemofiltration (CVVH) may affect plasma lev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::070e79905357bc466bcbf96106e446da
https://research.vumc.nl/en/publications/804bdf0e-0f35-48d4-bf2e-81cf0a9e6271
https://research.vumc.nl/en/publications/804bdf0e-0f35-48d4-bf2e-81cf0a9e6271
Autor:
Pieter M. ter Wee, Ilse M. Purmer, S Azam Nurmohamed, Frank H. Bosch, Marc G. Vervloet, Louise Schilder, Cynthia G. Kleppe, A. B. Johan Groeneveld, Armand R. J. Girbes, Sylvia S den Boer, Albertus Beishuizen
Publikováno v:
Critical Care
Critical Care, 18(4):472. Springer Science + Business Media
Schilder, L, Nurmohamed, S A, Bosch, F H, Purmer, I M, den Boer, S S, Kleppe, C G, Vervloet, M G, Beishuizen, A, Girbes, A R J, ter Wee, P M & Groeneveld, A B J 2014, ' Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial ', Critical Care, vol. 18, no. 4, 472 . https://doi.org/10.1186/s13054-014-0472-6
Critical Care, 18(4):472. Springer Science + Business Media
Schilder, L, Nurmohamed, S A, Bosch, F H, Purmer, I M, den Boer, S S, Kleppe, C G, Vervloet, M G, Beishuizen, A, Girbes, A R J, ter Wee, P M & Groeneveld, A B J 2014, ' Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial ', Critical Care, vol. 18, no. 4, 472 . https://doi.org/10.1186/s13054-014-0472-6
Introduction Because of ongoing controversy, renal and vital outcomes are compared between systemically administered unfractionated heparin and regional anticoagulation with citrate-buffered replacement solution in predilution mode, during continuous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72540899f9783311ac0569e7ea0b5edb
https://doi.org/10.1186/s13054-014-0472-6
https://doi.org/10.1186/s13054-014-0472-6
Autor:
Nayra Rico, S Azam Nurmohamed, Željko Župan, Peter Stenvinkel, Hiroshi Kawaguchi, Dean Markić, Zhihong Liu, Jiwei Zhang, Maksim Valenčić, Joachim Kuhn, Daxi Ji, Jean-Paul Cristol, Gregory A. Wilson, Pieter M. ter Wee, Albertus Beishuizen, Annie Rodrigez, Dorothea Baumann, Ken Tsuchiya, Sanjin Rački, Juan Jesus Carrero, Isabelle Jaussent, Buyun Wu, José María Martínez González, Stephan Thijssen, Jean-Pierre Vendrell, Yongmei Wang, Balwinder Singh, Druckerei Stückle, Ingvild Birschmann, Zhaohui Ni, Peter Kotanko, Kaiyue Zhang, Anders Larsson, Nanne J. Paauw, Armand R. J. Girbes, Mladen Ivanovski, Yijun Zhou, Masayuki Okazaki, Antun Gršković, Juan Sánchez, Axel C. Carlsson, Thomas Muehlbacher, Kianoush Kashani, Ferruh Artunc, Nathan W. Levin, Renhua Lu, Miquel Gómez, Johan Ärnlöv, Mizuki Komatsu, Nils Heyne, Louise Schilder, Marta Net, Marion Morena, Robert H.J. Beelen, Claudio Ronco, Nils Kuster, Leila Chenine, John C. Lieske, Garry J. Handelman, Mingli Zhu, Francisco Maduell, Stela Živčić-Ćosić, Xia Tao, Matteo Bottai, Sanjay Chaudhary, Myles Monaghan, Ognjen Gajic, Anton Maričić, Bin Xu, John J. Dillon, Dehua Gong, Rodrigo Cartin-Ceba, Kosaku Nitta, Myriam Vela, Andreas Peter, Božidar Vujičić, Néstor Rodríguez, A. B. Johan Groeneveld, Kristian Krpina, Abbasali Akhoundi, Marta Arias-Guillén, Josep M. Campistol, Bernard Canaud, Edouard Tuaillon, Peter Bárány
Publikováno v:
Blood Purification. 39:IV-V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1469bc5f13a4b26a88885cd6c34b43f0
https://doi.org/10.1159/000434735
https://doi.org/10.1159/000434735